Diclofenac topical - Futura Medical

Drug Profile

Diclofenac topical - Futura Medical

Alternative Names: TPR 100; TPR 100Rx

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Futura Medical
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Musculoskeletal pain; Pain

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Pain(In volunteers) in United Kingdom (Topical, Gel)
  • 23 Mar 2017 Futura Medical announces intention to submit MAA for Pain in United Kingdom in the second half of 2017
  • 01 Jan 2017 Diclofenac topical licensed to Thornton & Ross in United Kingdom
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top